Last updated on June 2019

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Brief description of study

The purpose of this study is to assess the efficacy and safety of ruxolitinib cream in adolescents and adults with atopic dermatitis (AD).

Clinical Study Identifier: NCT03745651

Find a site near you

Start Over

San Marcus Research Clinic Inc

Miami Lakes, FL United States
  Connect »

Derm Research LLC

Louisville, KY United States
  Connect »

Dermatology Specialists PSC

Louisville, KY United States
  Connect »

Michael W Simon MD Office

Nicholasville, KY United States
  Connect »

Hamzavi Dermatology

Fort Gratiot, MI United States
  Connect »

Paddington Testing Company Inc

Philadelphia, PA United States
  Connect »

Epiphany Dermatology Fort Worth

Fort Worth, TX United States
  Connect »

Center for Clinical Studies

Webster, TX United States
  Connect »

Tanner Clinic

Layton, UT United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.